tiprankstipranks
Trending News
More News >
Sana Biotechnology (SANA)
NASDAQ:SANA
US Market
Advertisement

Sana Biotechnology (SANA) Stock Statistics & Valuation Metrics

Compare
679 Followers

Total Valuation

Sana Biotechnology has a market cap or net worth of $833.02M. The enterprise value is $659.48M.
Market Cap$833.02M
Enterprise Value$659.48M

Share Statistics

Sana Biotechnology has 258,702,030 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding258,702,030
Owned by Insiders30.53%
Owned by Institutions0.07%

Financial Efficiency

Sana Biotechnology’s return on equity (ROE) is -1.06 and return on invested capital (ROIC) is -58.26%.
Return on Equity (ROE)-1.06
Return on Assets (ROA)-0.53
Return on Invested Capital (ROIC)-58.26%
Return on Capital Employed (ROCE)-0.60
Revenue Per Employee0.00
Profits Per Employee-1.38M
Employee Count194
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Sana Biotechnology is ―. Sana Biotechnology’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value1.50
Price to FCF
Price to Operating Cash Flow-4.39
PEG Ratio

Income Statement

In the last 12 months, Sana Biotechnology had revenue of 0.00 and earned -266.76M in profits. Earnings per share was -1.16.
Revenue0.00
Gross Profit-15.49M
Operating Income-272.72M
Pretax Income-266.76M
Net Income-266.76M
EBITDA-251.27M
Earnings Per Share (EPS)-1.16

Cash Flow

In the last 12 months, operating cash flow was -180.74M and capital expenditures -4.55M, giving a free cash flow of -185.29M billion.
Operating Cash Flow-180.74M
Free Cash Flow-185.29M
Free Cash Flow per Share-0.72

Dividends & Yields

Sana Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.25
52-Week Price Change-47.30%
50-Day Moving Average3.65
200-Day Moving Average2.69
Relative Strength Index (RSI)40.87
Average Volume (3m)5.60M

Important Dates

Sana Biotechnology upcoming earnings date is Nov 5, 2025, After Close (Confirmed).
Last Earnings DateAug 11, 2025
Next Earnings DateNov 5, 2025
Ex-Dividend Date

Financial Position

Sana Biotechnology as a current ratio of 3.54, with Debt / Equity ratio of 69.76%
Current Ratio3.54
Quick Ratio3.54
Debt to Market Cap0.00
Net Debt to EBITDA0.13
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Sana Biotechnology has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Sana Biotechnology EV to EBITDA ratio is -1.37, with an EV/FCF ratio of -1.34.
EV to Sales0.00
EV to EBITDA-1.37
EV to Free Cash Flow-1.34
EV to Operating Cash Flow-1.54

Balance Sheet

Sana Biotechnology has $72.67M in cash and marketable securities with $85.49M in debt, giving a net cash position of $12.82M billion.
Cash & Marketable Securities$72.67M
Total Debt$85.49M
Net Cash$12.82M
Net Cash Per Share$0.05
Tangible Book Value Per Share$0.22

Margins

Gross margin is -19.12%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-19.12%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Sana Biotechnology is $10.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$10.00
Price Target Upside210.56% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast
EPS Growth Forecast7.58%

Scores

Smart Score8
AI Score33
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis